Viewing Study NCT01945359


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-01-29 @ 9:50 PM
Study NCT ID: NCT01945359
Status: COMPLETED
Last Update Posted: 2015-10-16
First Post: 2013-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
Sponsor: Rocky Mountain MS Research Group, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing Multiple Sclerosis View
None Dimethyl Fumarate View
None Natalizumab View